Metabolism - Clinical and Experimental
Volume 44, Issue 7 , Pages 906-913, July 1995

Development of insulin secretory function in young obese hyperglycemic mice (Umeå )

  • Anders Edvell

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Anders Edvell, MD, Department of Histology and Cell Biology, Umeå University, S-90187 Umeå, Sweden.
  • ,
  • Per Lindström

Department of Histology and Cell Biology, Umeå University, Umeå, Sweden

Received 12 May 1994; accepted 20 November 1994.

Abstract 

The obese-hyperglycemic syndrome is well characterized in adult mice. However, little is known about islet morphology and function at an early age when obese mice islets start to proliferate. We have now studied islet morphology and functional development in obese-hyperglycemic mice (Umeå) and their lean littermates at ages ≤38 days. The weight of obese mice began to increase more than that of the lean littermates at days 8 to 12. At day 18, clinical diagnosis of the syndrome could be made with 100% certainty. Islets from obese mice started to show enhanced growth rate during week 4, coinciding with the time of onset of hyperglycemia. 3H-thymidine labeling index is enhanced in mice from day 22. Insulin secretion in islets from mice aged 18 to 21 days was the same in obese and lean mice from the same litter. At days 30 to 33, second-phase release and islet insulin content were decreased in islets from obese animals, but were restored after an overnight fast. It is likely that the hyperglycemia rather than increased insulin demand triggers increased β-cell growth.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the Swedish Medical Research Council (12X-7124), Swedish Diabetes Association, Swedish Hoechst Diabetes Foundation, Sahlberg Foundation, and the Medical Faculty, Umeå University.

PII: 0026-0495(95)90244-9

Metabolism - Clinical and Experimental
Volume 44, Issue 7 , Pages 906-913, July 1995